See Our Current Investments

CBD

May 25th

Neurotech Demonstrates Potential Benefits for Management of Multiple Sclerosis Disease
Revenue generating BDA sets its sights on US market

March 17th 2021

Revenue generating BDA sets its sights on US market
Neurotech expands exclusive license to include all neurological disorders

March 2nd 2021

Neurotech expands exclusive license to include all neurological disorders
Neurotech’s key near-term objectives

January 21st 2021

Neurotech’s key near-term objectives
$2M in repeat purchase orders display Creso Pharma’s growth potential

October 13th 2020

$2M in repeat purchase orders display Creso Pharma’s growth potential
How (and why) companies are mixing Terpenes into Cannabis Distillates

May 29th 2020

How (and why) companies are mixing Terpenes into Cannabis Distillates
Creso Pharma set to expand human health product line with technological breakthrough

February 6th 2020

Creso Pharma set to expand human health product line with technological breakthrough
Roots extends sales relationship with Israeli cannabis company

February 5th 2020

Roots extends sales relationship with Israeli cannabis company
BPH investee signs JV with cutting edge cannabis researcher

January 28th 2020

BPH investee signs JV with cutting edge cannabis researcher

Subscribe for updates on our small cap, ASX listed biotech portfolio.

Thanks for subscribing!

X